dihydroxyphenylalanine has been researched along with Burning Mouth Syndrome in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Burning Mouth Syndrome: A group of painful oral symptoms associated with a burning or similar sensation. There is usually a significant organic component with a degree of functional overlay; it is not limited to the psychophysiologic group of disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jääskeläinen, SK | 1 |
| Rinne, JO | 1 |
| Forssell, H | 1 |
| Tenovuo, O | 1 |
| Kaasinen, V | 1 |
| Sonninen, P | 1 |
| Bergman, J | 1 |
1 other study available for dihydroxyphenylalanine and Burning Mouth Syndrome
| Article | Year |
|---|---|
Role of the dopaminergic system in chronic pain -- a fluorodopa-PET study.
Topics: Adult; Aged; Burning Mouth Syndrome; Chronic Disease; Dihydroxyphenylalanine; Female; Humans; Middle | 2001 |